3652 results for «303»

Filter By

3652 results

The most impactful trials of 2025

10 Dec 2025 – From GulfPCR-GIM 2025

Review the most impactful cardiovascular intervention trials anticipated in 2025, analyzing their methodology and clinical applicability. This session facilitates understanding how emerging evidence can be integrated into daily interventional cardiology practice.

The most impactful trials of 2025

Challenging TAVI cases - Part 1

10 Dec 2025 – From GulfPCR-GIM 2025

Addressing complex TAVI cases, this session focuses on procedural challenges and advanced strategies to optimize safety and outcomes. Topics include high-risk valvuloplasty, management with prosthetic valves, and considerations in patients with valve thrombus.

Challenging TAVI cases - Part 1

Complex CTO interventions - Part 1

10 Dec 2025 – From GulfPCR-GIM 2025

Explore advanced techniques in complex chronic total occlusion (CTO) interventions, featuring IVUS-guided retrograde wire facilitated antegrade approaches, novel multiwire plaque modification for uncrossable in-stent restenosis CTOs, and strategic navigation through challenging scenarios. This session highlights key procedural insights and complication management strategies essential for success in...

Complex CTO interventions - Part 1

GulfPCR-GIM 2025 Opening Ceremony

10 Dec 2025 – From GulfPCR-GIM 2025

The GulfPCR-GIM 2025 Opening Ceremony marks the commencement of this prestigious cardiology congress, setting the tone for a comprehensive program dedicated to advancing interventional cardiology practice and research in the Gulf region and beyond.

GulfPCR-GIM 2025 Opening Ceremony

GulfPCR-GIM 2025 Closing Ceremony

11 Dec 2025 – From GulfPCR-GIM 2025

The GulfPCR-GIM 2025 Closing Ceremony marks the conclusion of an insightful and comprehensive congress, highlighting the latest advances and discussions in interventional cardiology. This session encapsulates the key takeaways and emerging themes that will shape future clinical practice and research in cardiology.

GulfPCR-GIM 2025 Closing Ceremony

Seeing is believing: OCT-guided calcium modification in complex PCI

10 Dec 2025 – From GulfPCR-GIM 2025

Explore the management of heavily calcified LAD lesions in this PCRGulf-GIM 2025 session. Discover how OCT imaging guides lesion assessment, differentiates superficial from deep calcium, and informs the need for plaque modification. Learn when and how to use orbital atherectomy or intravascular lithotripsy, and follow the...

Seeing is believing: OCT-guided calcium modification in complex PCI

Beyond the trial: how will SELUTION DeNovo redefine our PCI practice?

10 Dec 2025 – From GulfPCR-GIM 2025

This session looks beyond trial data to examine how the SELUTION DeNovo study may reshape PCI practice in real-world settings.

The discussion reviews key clinical results from this large-scale DeNovo PCI trial and explains the technology behind the SELUTION SLR drug-eluting balloon, including its slow-flow drug delivery...

Beyond the trial: how will SELUTION DeNovo redefine our PCI practice?

Cracking calcium in modern PCI

10 Dec 2025 – From GulfPCR-GIM 2025

Calcified coronary lesions are a major challenge in PCI. This PCRGulf-GIM 2025 session showcases a complex case with intravascular imaging, highlighting how IVUS 123 guides each step.

From planning the procedure and understanding calcium distribution, to lesion preparation with modern modification tools, and post-PCI assessment to confirm...

Cracking calcium in modern PCI

Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial

20 Sep 2022

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

Nicola Ryan

Author

Nicola Ryan
10-Year Outcomes of Multicenter Randomized Controlled BEST Trial: Everolimus-Eluting Stents or Bypass Surgery for Mutivessel CAD

3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications

22 Mar 2022

Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.

Author

Ali Nazmi Calik
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications

INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes

03 Sep 2024

Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.

Daniele Giacoppo

Author

Daniele Giacoppo
INFINITY-SWEDEHEART

Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

29 Mar 2025

Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.

Nicola Ammirabile

Author

Nicola Ammirabile
Daniele Giacoppo

Author

Daniele Giacoppo
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
Didn’t find what you were looking for?